Glaukos Corporation

(GKOS) Trade

By |

Profile

Glaukos Corp is an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures designed to transform the treatment of glaucoma.

Contact Information

Website: www.glaukos.com
Main Phone: +1 949 367-9600
Address: 229 Avenida Fabricante
Address 2: Suite 103
State: CA
City / Town: San Clemente
Country: USA
Postal Code: 92672

Issuer Information

Exchange: NYE
CEO: Thomas W. Burns
Employees: 132
NAICS: Surgical and Medical Instrument Manufacturing(339112)
$ 58.84 $ -1.61 (-2.66%)
Last Price 58.84 Change $ -1.61 Change % -2.66 Tick N/A
Bid N/A Bid Size 0.00 Ask N/A Ask Size 0.00
Open 60.28 High 60.86 Low 58.11 Prev Close 60.45
Last Trade Volume 712,069 52 Wk Hi 70.91 52 Wk Low 23.08
Market Cap 2.1 bi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 35,255,010.00 EPS (TTM) -0.16 PE Ratio N/A Exchange NYSE
  Last 3 Mo Last 12 Mo
Number of Insider Trades 1 41
Number of Buys 0 8
Number of Sells 1 33
Net Activity -8883 -1676812
Last 10 Buys Shares
Joseph E. Gilliam 1,000
Aimee S. Weisner 1,000
Richard L. Harrison 1,000
Thomas W. Burns 1,000
Aimee S. Weisner 1,000
Robert J. More 1,000
Last 10 Sell Shares
Jonathan T. Silverstein 1,000
Jonathan T. Silverstein 1,000
Jonathan T. Silverstein 1,000
Jonathan T. Silverstein 1,000
Jonathan T. Silverstein 1,000
Jonathan T. Silverstein 1,000
Jonathan T. Silverstein 1,000
Jonathan T. Silverstein 1,000
Jonathan T. Silverstein 1,000
Jonathan T. Silverstein 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 49 49 49 49
Low Target Price Estimate 32 32 32 32
Mean Target Price Estimate 40.71 39.29 39.29 40.71
Standard Deviation 5.41 5.82 5.82 5.41
Date of Most Recent Estimate 06/04/18 05/10/18 05/10/18 06/04/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 7 8 8 9
Moderate Buy 0 0 0 0
Hold 1 1 1 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.25 1.22 1.22 1